BlackRock’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.08M | Sell |
341,523
-42,776
| -11% | -$164K | ﹤0.01% | 4320 |
|
|
2025
Q4 | $1.86M | Buy |
+384,299
| New | +$1.61M | ﹤0.01% | 4132 |
|
|
2024
Q4 | – | Sell |
-2,755
| Closed | -$5.84K | – | 5400 |
|
|
2024
Q3 | $5.84K | Hold |
2,755
| – | – | ﹤0.01% | 5032 |
|
|
2024
Q2 | $5.15K | Hold |
2,755
| – | – | ﹤0.01% | 5122 |
|
|
2024
Q1 | $7.3K | Hold |
2,755
| – | – | ﹤0.01% | 5112 |
|
|
2023
Q4 | $8.48K | Hold |
2,755
| – | – | ﹤0.01% | 5155 |
|
|
2023
Q3 | $4.35K | Hold |
2,755
| – | – | ﹤0.01% | 5255 |
|
|
2023
Q2 | $5.42K | Hold |
2,755
| – | – | ﹤0.01% | 5304 |
|
|
2023
Q1 | $5.32K | Hold |
2,755
| – | – | ﹤0.01% | 5367 |
|
|
2022
Q4 | $5.79K | Sell |
2,755
-278,946
| -99% | -$632K | ﹤0.01% | 5511 |
|
|
2022
Q3 | $645K | Sell |
281,701
-8,324
| -3% | -$25.2K | ﹤0.01% | 4640 |
|
|
2022
Q2 | $821K | Sell |
290,025
-12,484
| -4% | -$44K | ﹤0.01% | 4610 |
|
|
2022
Q1 | $1.37M | Sell |
302,509
-24,775
| -8% | -$136K | ﹤0.01% | 4547 |
|
|
2021
Q4 | $2.66M | Buy |
327,284
+15,028
| +5% | +$148K | ﹤0.01% | 4287 |
|
|
2021
Q3 | $3.94M | Buy |
312,256
+17,387
| +6% | +$241K | ﹤0.01% | 4038 |
|
|
2021
Q2 | $4.56M | Buy |
294,869
+99,370
| +51% | +$1.67M | ﹤0.01% | 3915 |
|
|
2021
Q1 | $3.95M | Buy |
195,499
+36,836
| +23% | +$911K | ﹤0.01% | 4042 |
|
|
2020
Q4 | $4.29M | Sell |
158,663
-16,845
| -10% | -$378K | ﹤0.01% | 3773 |
|
|
2020
Q3 | $3.25M | Sell |
175,508
-8,775
| -5% | -$156K | ﹤0.01% | 3752 |
|
|
2020
Q2 | $3.28M | Buy |
184,283
+36,351
| +25% | +$553K | ﹤0.01% | 3680 |
|
|
2020
Q1 | $1.36M | Sell |
147,932
-10,236
| -6% | -$153K | ﹤0.01% | 3776 |
|
|
2019
Q4 | $2.71M | Sell |
158,168
-10,424
| -6% | -$139K | ﹤0.01% | 3685 |
|
|
2019
Q3 | $1.75M | Buy |
168,592
+2,741
| +2% | +$36.9K | ﹤0.01% | 3797 |
|
|
2019
Q2 | $2.59M | Sell |
165,851
-315,739
| -66% | -$5.64M | ﹤0.01% | 3690 |
|
|
2019
Q1 | $8.83M | Sell |
481,590
-10,228
| -2% | -$181K | ﹤0.01% | 3176 |
|
|
2018
Q4 | $8.19M | Sell |
491,818
-13,130
| -3% | -$304K | ﹤0.01% | 3190 |
|
|
2018
Q3 | $14.3M | Buy |
504,948
+61,235
| +14% | +$1.76M | ﹤0.01% | 3050 |
|
|
2018
Q2 | $12.6M | Buy |
443,713
+320,340
| +260% | +$9.54M | ﹤0.01% | 3121 |
|
|
2018
Q1 | $3.89M | Sell |
123,373
-28,323
| -19% | -$895K | ﹤0.01% | 3492 |
|
|
2017
Q4 | $4.42M | Buy |
+151,696
| New | +$4.13M | ﹤0.01% | 3483 |
|
|
2017
Q2 | – | Sell |
-200
| Closed | -$5K | – | 5025 |
|
|
2017
Q1 | $5K | Sell |
200
-700
| -78% | -$14.7K | ﹤0.01% | 4791 |
|
|
2016
Q4 | $15K | Buy |
+900
| New | +$16.6K | ﹤0.01% | 3309 |
|
|
2015
Q4 | – | Sell |
-29,400
| Closed | -$775K | – | 3443 |
|
|
2015
Q3 | $775K | Hold |
29,400
| – | – | ﹤0.01% | 1380 |
|
|
2015
Q2 | $1.06M | Sell |
29,400
-1,800
| -6% | -$63.2K | ﹤0.01% | 1333 |
|
|
2015
Q1 | $1.08M | Buy |
+31,200
| New | +$1.13M | ﹤0.01% | 1316 |
|
Other funds holding CLLS
BGI
LFCM
NAMI
BlackRock's CLLS Position: Q1 2026 in Review
BlackRock reduced its Cellectis (CLLS) stake by 11% in Q1 2026, selling an estimated $164K and leaving 341,523 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #4320.
BlackRock first reported a position in CLLS in Q1 2015 and has held it in 35 quarters since. The position peaked at $14.3M in Q3 2018. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.
- BlackRock held 341,523 shares of Cellectis worth $1.08M as of Q1 2026.
- BlackRock sold 42,776 Cellectis shares in Q1 2026, an estimated $164K.
- Cellectis made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4320 holding.
- BlackRock first reported a position in Cellectis in Q1 2015 and has held it in 35 quarters since.
- BlackRock's Cellectis position peaked at $14.3M in Q3 2018.
- 32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.